Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Avani Yeola
Observed names:
A. Yeola,
Yeola, Avani
Institution:
Children's Hospital at Westmead
Observed institutions:
The University of Sydney,
Indian Institute of Technology Bombay,
King Edward Memorial Hospital,
Children's Hospital at Westmead,
Westmead Hospital,
UNSW Sydney,
ICMR - National Institute of Immunohaemotology
show all 7
ORCID:
0000-0003-4210-1371
Observed ORCID:
0000-0003-4210-1371
OpenAlex ID:
A5015475208
PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells
2016
·
Vashe Chandrakanthan
, Avani Yeola
, et al.
·
Proceedings of the National Academy of Sciences
·
51
Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy
2023
·
Katherine Rankin
, Priyanka Hastak
, et al.
·
eJHaem
·
11
PDF
Proteomic level changes associated with S3I201 treated U87 glioma cells
2016
·
Rekha Jain
, Apurva Atak
, et al.
·
Journal of Proteomics
·
8
Distribution of HLA-DRβ1 alleles among well-characterized rheumatoid arthritis patients from Western India
2013
·
Devaraj J. Prasannavar
, A. Yeola
, et al.
·
Rheumatology International
·
8
Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
2023
·
Aleha Pillay
, Avani Yeola
, et al.
·
Journal of Clinical Immunology
·
7
PDF
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
2021
·
Avani Yeola
, Shruthi Subramanian
, et al.
·
Science Advances
·
6
HLA-DRβ1*04 typing by simple in-house PCR-SSP technique for rheumatoid arthritis patients
2012
·
Devaraj Jatteppa Parasannanavar
, Avani Yeola
, et al.
·
Rheumatology International
·
4
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection
2025
·
Avani Yeola
, Samuel Houston
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
1
6 Spike antibody seroconversion and emerging variant cross-reactivity following COVID-19 third vaccination dose in Australian people with multiple Sclerosis
2023
·
Aleha Pillay
, Avani Yeola
, et al.
·
BMJ Neurology Open
PDF
2432 Spike antibody seroconversion and breadth following SARS-CoV-2 vaccination in Australian people with Multiple Sclerosis
2022
·
Aleha Pillay
, Avani Yeola
, et al.
·
BMJ Neurology Open
PDF
Show more works
View as search
Works count:
13
Citation count:
96
H-index:
6
I10-index:
2
Year
Topic
Type